Medable Launches Clinical Trial Platform on Google Cloud Marketplace, Expands AI Integration

Medable Inc. has launched its Digital and Decentralized Clinical Trial Platform on Google Cloud Marketplace, bringing advanced trial management and design tools directly to life sciences organizations through Google’s cloud infrastructure. This collaboration allows companies to integrate Medable’s Studio platform—a SaaS solution built for precise trial design and transparent execution—alongside Google Cloud’s AI and data capabilities, enabling seamless trial management within a unified, secure environment.

By listing on Google Cloud Marketplace, Medable provides customers a consolidated billing structure and allows them to apply committed Google Cloud spend toward Medable usage. This structure aims to simplify procurement and enhance accessibility, with the platform optimized for both enterprise and hybrid cloud setups.

Dai Vu, Managing Director of Google Cloud Marketplace, emphasized the infrastructure’s role:

“Bringing Medable’s platform to Google Cloud Marketplace will help customers quickly deploy, manage, and expand their use of the AI-driven clinical trial platform on Google Cloud's trusted, global infrastructure.”

With a record of over 300 decentralized and hybrid trials across 60 countries, Medable has demonstrated success in accelerating patient enrollment rates by 200% and reducing trial costs by 50%. Tufts CSDD research further estimates decentralized trials can deliver five to 13 times ROI for Phases II and III, a substantial gain for life sciences companies investing in scalable technology.

See also: Rethinking Clinical Trials: Tim Smith on Medable’s Approach to Speed and Efficiency

At the recent Cancer AI Symposium hosted by Google Cloud, Medable's CEO, Dr. Michelle Longmire, discussed the integration of cloud-based AI with decentralized clinical trials, focusing on enhancing trial accessibility and efficiency.

About the Medable Platform

Medable’s platform offers an integrated, cloud-based solution tailored for clinical research, providing tools to streamline operations across sites, participants, and sponsors:

• Medable Studio: A no-code trial design and management interface allowing teams to create assessments and schedules with live previews, automated testing, and global translation capabilities. This tool simplifies the study design process, reducing setup time and enhancing data consistency.

• eCOA+ (electronic Clinical Outcome Assessment): Combines patient-reported outcomes with data from connected sensors for immediate, high-quality data capture. The eCOA+ library includes over 380 pre-validated instruments in 120 languages, designed to improve data quality and reduce data-cleaning time for faster insights.

• Total Consent: A digital consent management solution that supports remote and on-site enrollment, enabling compliant digital consent in over 60 countries. Total Consent is designed to improve participant retention, reduce compliance errors, and provide real-time visibility into consent activities.

Medable Studio; Source: Medable

Medable’s platform is built to be globally compliant, supporting standards such as FDA 21 CFR Part 11, ICH E6 (R2), and GDPR. This platform aims to make clinical trials more accessible, efficient, and scalable, addressing the complex needs of life sciences companies across diverse therapeutic areas.

Topics: Clinical Trials